The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure

NCT01739933 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

438

Enrollment

OTHER

Sponsor class

Conditions

Sepsis
Delirium
Impaired Cognition

Interventions

DRUG: Dexmedetomidine
DRUG: Propofol

Sponsor

Vanderbilt University Medical Center